Tag - MDCI

Small-cap stocks are up slightly in Friday afternoon action, after dipping in the morning and then treading higher in midday trading. At 1:42 p.m. ET, the Russell 2000 (NYSE:IWM) was up 0.71, or 0.1%, at 746.26.

The Chicago Purchasing Manager’s Survey came in at 49.1, which was above the forecast at 48.5. Although the reading was slightly above expectations, it had only a muted impact on stock prices as the number was still below 50 for the fourth consecutive month.

Also, the Michigan sentiment survey came in at 59.8, just slightly above the forecast of 59.5, but still at 28-year lows.

Market sectors showing strength include metal mining, coal energy, iron and steel, gold and silver, and oil and gas operations. Sectors attracting sellers include school services, forestry and wood products, computer accessories, non-cyclical crops and tobacco.

Individual small caps on the move include RXi Pharmaceuticals Corp. (Nasdaq:RXII), which is up some 18% despite no fresh news. ChemGenex Pharmaceuticals Ltd. (Nasdaq:CXSP) is similarly up 16%, also without any significant announcements. Sourcefire, Inc. (Nasdaq:FIRE) is getting a 15% boost after rejecting a buyout bid.

On the downside, Medical Action Industries (Nasdaq:MDCI) is diving 21% on earnings-related news. Sigma Designs Inc. (Nasdaq:SIGM) is tumbling about 18% after missing the sales forecast. WGNB Corp. (Nasdaq:WGNB) is falling 11% . . .